Interestingly, high expression of both Pkm2 and Mct4 has previously been reported in various cancer cell types, which are well known for their highly glycolytic activity (Pérez‐Escuredo et al. 2016; Zhu et al. 2021). The gene discussed is SLC16A3; the disease is cancer.